The Good, the “Bad,” and the Good “Good” (Cholesterol)
Godfrey Getz, M.D., Catherine Reardon, and Geoffrey Wool. In the vanguard of a new generation of promising drug therapies for treating atherosclerosis with “good” cholesterol (high density lipoprotein, or HDL) is an agent being developed by Godfrey Getz, MD, PhD,… Keep reading